用于电治疗的β抑制剂:系统性审查和元分析
Toshiyuki Shimizu1, Yoshiteru Takekita1, Nobuatsu Aoki1
1Department of Neuropsychiatry, Faculty of Medicine, Kansai Medical University, Osaka, Japan.
Journal of psychiatric research
|February 27, 2025
概括
将β阻塞剂添加到电疗法 (ECT) 中,可显著降低刺激后的最大心率. 这次元分析没有发现不良事件的风险增加,这表明患者的ECT体验更安全.
科学领域:
- 心脏病学 心脏病学
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 电疗法 (ECT) 是严重心理健康状况的重要治疗方法.
- 电磁心电可以引起显著的心血管副作用,包括心率加快和心律失常.
- 管理这些血液动力学波动对于ECT期间的患者安全至关重要.
研究的目的:
- 系统地审查和元分析beta阻断剂增强在ECT期间对心血管反应的影响.
- 评估β抑制剂对最大心率和ECT刺激后不良事件发生的影响.
- 为了确定使用β阻塞剂减轻ECT诱导的血液动力学不稳定性的安全性和有效性.
主要方法:
- 随机对照试验 (RCT) 的系统性审查和元分析,比较β阻塞剂加ECT与通常治疗 (TAU).
- 纳入标准集中在评估心血管影响和不良事件的RCT上.
- 主要结局包括最大心率和不良事件的发生率.
主要成果:
- 贝塔阻断剂组显示,刺激后最大心率显著降低 (MD = 21.98,p < 0.01).
- 与TAU相比,beta阻断剂组中没有观察到不良事件风险的显著增加 (RR = 1.44,p = 0.11).
- 小组和灵敏度分析证实了这些发现的可靠性.
结论:
- 在ECT方案中添加β抑制剂有效地稳定了刺激后的心率.
- 在ECT期间使用β阻塞剂似乎不会增加心血管不良事件的风险.
- β抑制剂可能是接受ECT的高风险患者的有益补充剂,改善耐受性和安全性.
相关概念视频
01:27Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
01:22Heart Failure Drugs: β-Blockers
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
01:30Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...